Biotech RadarJobs updated

COMPANY

Coordination Pharmaceuticals, Inc.

HQ: Elk Grove Village, IL source · coordinationpharma.com ↗

Clinical Phase 2

Also known as Coordination Pharmaceuticals · 6 sources

Location: Elk Grove Village, IL · source · Sep 14, 2021

Profile checked Oct 10, 2026

Keywords: Intratumoral Injection Head Neck Cancer RiMO-301 RiMO-401 CPI-300 CPI-100 CPI-200

6Trials (company is sponsor)

Timeline

  1. Trial start I: Phase I Study of RiMO-401 With Radiation in Advanced Tumors source ↗
  2. Trial start Phase 1/Phase 2: Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer source ↗
  3. Trial start I: Phase I Study of CPI-300 in Patients With Advanced Tumors source ↗
  4. Trial start Phase 1: Study of CPI-200 in Patients With Advanced Tumors source ↗
  5. Trial start Phase 1: Study of CPI-100 in Patients With Advanced Tumors source ↗
  6. Trial start I: Phase I Study of RiMO-301 With Radiation in Advanced Tumors source ↗

Clinical trials (lead sponsor) 6

RecordTitlePhaseStatusStartPrimary completion
NCT06182579Phase I Study of RiMO-401 With Radiation in Advanced TumorsITerminatedFeb 22, 2024Jun 16, 2025 (actual)
NCT05838729Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck CancerPhase 1/Phase 2RecruitingApr 3, 20232026-09 (estimated)
NCT03444714Phase I Study of RiMO-301 With Radiation in Advanced TumorsICompletedApr 10, 2018Jun 16, 2025 (actual)
NCT04808453Phase I Study of CPI-300 in Patients With Advanced TumorsICompletedJun 15, 2021Dec 15, 2023 (actual)
NCT03781362Study of CPI-100 in Patients With Advanced TumorsPhase 1CompletedDec 21, 2018Jun 21, 2022 (actual)
NCT03953742Study of CPI-200 in Patients With Advanced TumorsPhase 1CompletedJul 1, 2019Feb 1, 2022 (actual)
Feedback